STAT+: South Africa official explains why world trade rules should be waived to fight Covid-19
Last fall, the governments of India and South Africa asked the World Trade Organization to…
Category: Pharma
STAT+: Pharmalittle: A race is on to find alternatives to syringes and needles for vaccines; FDA under pressure to inspect more plants
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
Opinion: The Biden administration’s pandemic agenda must not ignore superbugs
What if another devastating pandemic came on the heels of Covid-19? Unfortunately, that looks increasingly…
STAT+: Pharmalittle: Merck will help J&J make its Covid-19 vaccine; Trump used hospital funds to bankroll Warp Speed
Rise and shine, another busy day is on the way. We can tell because our…
STAT+: A nascent state effort would tax drug makers for not providing clinical evidence for price hikes
In a bid to control the cost of medicines, lawmakers in two states — Hawaii…
STAT+: New Mexico attorney general accuses Gilead of blocking competition to its HIV medicines
The New Mexico attorney general has filed a lawsuit against Gilead Sciences (GILD) and two…
STAT+: Pharmalittle: J&J Covid-19 vaccine supply will be uneven; pandemic ushers in a ‘golden age of vaccinology’
Good morning, everyone, and welcome to another working week. We hope the weekend respite —…
.jpg)
Opinion: Why drug prescriptions should include diagnoses
The Covid-19 pandemic is teaching us many tragic lessons along with some instructive ones, like…
STAT+: Pharmalittle: Sarepta wins another FDA nod; Germans balk at AstraZeneca vaccine
Good morning, one and all. Damian Garde here, filling in for Ed Silverman in the…
STAT+: The vial is not half empty: New report lays out ways to address the issue of discarded drugs
File this under ‘Waste not, want not.’ In response to the cost of medicines, a…
STAT+: Pharmalittle: Moderna proceeds with a vaccine trial to combat Covid-19 variant; who will be the next FDA commish?
Top of the morning to you, and a fine one it is. Once again, clear…
STAT+: A U.S. court ruling may force biologics makers to review patent protections
In a decision with broad implications for the pharmaceutical industry, a U.S. appeals court recently…
Challenging the link between statins and muscle pain, patients report no difference in aches when taking drug or placebo
Statins — among the most successful drugs ever developed — prevent deaths from heart attacks…
STAT+: Once again, the credit outlook for the pharmaceutical industry is negative
For the eighth consecutive year, the credit outlook for the pharmaceutical industry is negative and…
STAT+: Pharmalittle: FDA scientists say J&J Covid-19 shot is effective; vaccine makers predict big jump in deliveries this month
Good morning, everyone, and how are you today? We are doing just fine, thanks to…
Opinion: Three steps can help companies speed FDA approval of new drugs
Drug developers see Food and Drug Administration approval as a difficult uphill climb, requiring large…
STAT+: Access to heart drugs improves in middle-income countries, but still lags compared to wealthy nations
Middle-income countries have gained greater access to a variety of needed cardiovascular medicines, but remain…
STAT+: Pharmalittle: Pfizer accused of ‘bullying’ some countries during vaccine talks; FDA to quickly analyze Covid-19 booster shots
Rise and shine, everyone, another busy day is on the way. This morning is getting…
Dozens of institutional investors push for ‘fair and equitable’ Covid-19 response
Nearly 150 institutional investors that oversee combined assets worth more than $14 trillion have issued…
‘Held to ransom’: Pfizer plays hardball in Covid-19 vaccine negotiations with Latin American countries
Pfizer has been accused of “bullying” Latin American governments during negotiations to acquire its Covid-19…
New pledges boost a global vaccine access program, but critics say more is needed
After months of uncertainty and frustration, a World Health Organization program designed to ensure access…
STAT+: Pharmalittle: Glaxo and Sanofi start new trial of Covid-19 vaccine; AstraZeneca ends a drug’s use for bladder cancer after failed trial
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: AbbVie smooths over a dispute about alleged theft of trade secrets for a new version of Botox
After two years of bickering, AbbVie (ABBV) and a marketing partner have settled a dispute…
STAT+: Pharmalittle: Single Pfizer shot is 85% effective in preventing symptomatic Covid-19; Biden to commit $4 billion to COVAX
And so, another working week will soon draw to a close. Not a moment too…
Pharmalittle: Pfizer vaccine seems less potent against Covid-19 variant in lab test; WTO urges end to vaccine export restrictions
Hello, everyone, and how are you today? We are doing just dandy, despite another blanket…
Pharma’s ambitious new antibiotic venture hires a CEO to fix a ‘broken’ pipeline
Several months after a splashy announcement, an ambitious pharmaceutical industry venture to tackle antibiotic resistance…
STAT+: Pharmalittle: First Covid-19 human challenge study to begin; vaccine firm executives profit from insider stock sales
Top of the morning to you. Another busy day is unfolding here on the Pharmalot…
Opinion: Ultra-rare but not forgotten: New drug development paradigms to treat the rarest of diseases
In addition to the most visible effects of Covid-19 — tragic deaths, lingering illness, economic…
Novartis and the Gates Foundation aim to create a more practical gene therapy for sickle cell patients around the world
Novartis and the Bill and Melinda Gates Foundation are joining forces to discover and develop…
.jpg)
STAT+: FDA warns AcelRx of misleading ads for its pain drug Dsuvia
The manufacturer of Dsuvia, a pain drug approved by the Food and Drug Administration amid…
STAT+: After a controversial Alzheimer’s drug review, FDA’s Woodcock rejects proposal to ‘firewall’ agency and drug companies
In response to criticism, a top Food and Drug Administration official maintained that creating a…
STAT+: Pharmalittle: WHO approves AstraZeneca Covid-19 vaccine; North Korean hackers target Pfizer vaccine data
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Bristol Myers and Sanofi ordered to pay $834 million to Hawaii for withholding Plavix label
After years of litigation, a Hawaii court judge ordered Bristol Myers Squibb (BMY) and Sanofi…
Once again, senators want GAO to probe the role of PBMs in prescription drug pricing
In a bid to contain prescription drug prices, a pair of U.S. senators is re-introducing…
STAT+: Pharmalittle: An arthritis drug reduced Covid-19 death rates; impatience grows over choosing FDA commissioner
And so, another working week will soon draw to a close. Not a moment too…
By looking the other way, pharma money helped fuel a toxic political atmosphere in the U.S.
As the impeachment trial for former President Trump plays out, the pharmaceutical industry can thank…
STAT+: With a legislative veto, Maryland’s prescription drug affordability board moves forward
Following a vote by the Maryland House of Delegates, the state now has all the…
STAT+: Pharmalittle: Teva and Merck may help with Covid-19 vaccine production; $5 billion Gilead deal goes up in flames
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Drug maker agrees to plead guilty to hiding and destroying records before FDA inspection
A unit of Fresenius Kabi, a major supplier of infused and intravenously administered drugs, has…
STAT+: Drug maker will slash prices on cancer medicines to end price gouging probe in Europe
After months of deliberation, the European Commission has accepted an offer from Aspen Pharma to…
STAT+: Pharmalittle: House Dems slip drug pricing proposal into Covid-19 relief bill; FDA grants emergency use for Lilly drug
Top of the morning to you. Another busy day is unfolding here on the Pharmalot…
STAT+: To delight of generic drug makers, federal appeals court tosses controversial ‘skinny labeling’ decision
In a surprising move, a federal appeals court panel may revisit a controversial decision that…
STAT+: Pharmalittle: House to hold hearing on Covid-19 vaccine production; tug-of-war rages over who will be the next FDA commissioner
Rise and shine, everyone, another busy day is on the way. We can always tell,…
Opinion: The Biden administration needs to look beyond ICER for evaluating drug therapies
As breakthrough drugs stream out of biopharmaceutical laboratories, how much they should cost and who…
STAT+: A move to crack down on human rights, environmental abuses puts European pharma on notice
A new European plan to develop legislation to hold companies accountable for human rights abuses…
STAT+: Dueling endorsements emerge for FDA commissioner: Woodcock or Sharfstein?
As the White House struggles to address the pandemic and other pressing health matters, a…
STAT+: Pharmalittle: South Africa halts rollout of AstraZeneca Covid-19 vaccine; Pfizer to cut vaccine production time in half
Good morning, everyone, and welcome to another working week. We hope the weekend was somehow…
Opinion: Collaboration between the FDA and industry is essential to foster innovation in Alzheimer’s treatments
As the Food and Drug Administration moves closer to a decision about whether to approve…
STAT+: WTO is urged to ease trade rules so low-income countries can access drugs and vaccines
More than 100 advocacy groups from dozens of countries are urging the World Trade Organization…
STAT+: FDA blasts Keytruda data for new breast cancer indication as ‘questionable, immature, and unreliable’
Merck (MRK) may have readily turned its Keytruda cancer drug into a medical and financial…